Finance

Lists
RUBICON:NSE
Rubicon Research Ltd
₹1,823.80
+1.08%
(+19.40) 1D
Aug 31, 3:30:03 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RUBICON...
Open
₹1,812.00
High
₹1,855.00
Low
₹1,780.40
Mkt. cap
300.65B
Avg. vol.
0.00
Volume
319.23K
Dividend
0.08%
Quarterly dividend
₹0.37
Ex-dividend date
Aug 7, 2026
P/E ratio
104.49
52-wk high
₹1,899.00
52-wk low
₹570.75
EPS
₹17.45
No. of employees
1K
Open
₹1,812.00
High
₹1,855.00
Low
₹1,780.40
Mkt. cap
300.65B
Avg. vol.
0.00
Volume
319.23K
Dividend
0.08%
Quarterly dividend
₹0.37
Ex-dividend date
Aug 7, 2026
P/E ratio
104.49
52-wk high
₹1,899.00
52-wk low
₹570.75
EPS
₹17.45
No. of employees
1K
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai. The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1.29K
Founded1999
Headquarters-
SectorPharmaceutical industry
Websiterubicon.co.in
Last report
Aug 14, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹5.08 / ₹4.40
+15.45%beat
Revenue / Est. (INR)
5.34B / 5.13B
+4.20%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.12B
4.76B
5.14B
5.34B
Cost of goods sold
1.27B
1.57B
1.86B
1.69B
Cost of revenue
1.27B
1.57B
1.86B
1.69B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633.59M
663.73M
699.04M
856.66M
Operating expense
2.03B
2.22B
2.21B
2.51B
Total operating expenses
3.30B
3.79B
4.07B
4.20B
Operating income
824.26M
965.73M
1.06B
1.14B
Other non operating income
6.97M
37.87M
-157.07M
56.83M
EBT including unusual items
717.05M
905.86M
986.87M
1.10B
EBT excluding unusual items
717.05M
905.86M
996.82M
1.10B
Income tax expense
178.53M
177.89M
219.02M
255.91M
Effective tax rate
24.90%
19.64%
22.19%
23.19%
Other operating expenses
1.28B
1.44B
1.39B
1.51B
Net income
538.52M
727.97M
767.85M
847.81M
Net profit margin
13.07%
15.31%
14.94%
15.87%
Earnings per share
3.47
4.41
4.60
5.08
Interest and investment income
-
-
79.68M
-
Interest expense
-114.18M
-97.74M
-
-92.88M
Net interest expenses
-114.18M
-97.74M
79.68M
-92.88M
Depreciation and amortization charges
118.71M
115.53M
122.66M
151.39M
EBITDA
976.82M
1.12B
1.14B
1.21B
Gain or loss from assets sale
7.63M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps